药研通(参比购)-免费查询参比制剂目录,一站式代理进口全球参比制剂。
仿制药参比制剂目录(第二十二批)
序号 |
药品通用名称 | 英文名称/商品名 | 规格 | 剂型 | 持证商 | 备注1 | 备注2 | |
|---|---|---|---|---|---|---|---|---|
22-201 |
马来酸茚达特罗吸入粉雾剂 |
Indacaterol Maleate Powder for Inhalation/Onbrez(昂润) |
150 ug(以C24H28N2O3计) |
粉雾剂 |
Novartis Europharm Ltd. |
国内上市的原研药品 |
||
22-202 |
拉考沙胺片 |
Lacosamide Tablets/VIMPAT(维派特) |
50mg |
片剂 |
UCB Pharma SA |
国内上市的原研药品 |
||
22-203 |
拉考沙胺片 |
Lacosamide Tablets/VIMPAT(维派特) |
100mg |
片剂 |
UCB Pharma SA |
国内上市的原研药品 |
||
22-204 |
拉考沙胺片 |
Lacosamide Tablets/VIMPAT(维派特) |
150mg |
片剂 |
UCB Pharma SA |
国内上市的原研药品 |
||
22-205 |
拉考沙胺片 |
Lacosamide Tablets/VIMPAT(维派特) |
200mg |
片剂 |
UCB Pharma SA |
国内上市的原研药品 |
||
22-206 |
地氯雷他定口服溶液 |
Desloratadine oral solution/ Aerius/Azomyr Neoclarityn |
0.5mg/ml |
口服溶液剂 |
Merck Sharp & Dohme B.V./N.V. Organon |
未进口原研药品 |
||
22-207 |
盐酸可乐定缓释片 |
Clonidine hydrochloride extended-release tablets/KAPVAY |
0.1mg |
片剂 |
Concordia Pharmaceuticals Inc |
未进口原研药品 |
||
22-208 |
艾塞那肽注射液 |
Exenatide Injection/BYETTA(百泌达) |
10μg(0.25mg/ml,2.4ml/支) |
注射剂 |
AstraZeneca AB |
国内上市的原研药品 |
||
22-209 |
艾塞那肽注射液 |
Exenatide Injection/BYETTA(百泌达) |
5μg(0.25mg/ml,1.2ml/支) |
注射剂 |
AstraZeneca AB |
国内上市的原研药品 |
||
22-210 |
醋酸奥曲肽注射液 |
Octreotide Acetate Injection/ Sandostatin(善宁) |
1ml:0.1mg |
注射剂 |
Novartis Pharma Schweiz AG |
国内上市的原研药品 |
||
22-211 |
醋酸奥曲肽注射液 |
Octreotide Acetate Injection/SANDOSTATIN |
1ml:0.05mg |
注射剂 |
NOVARTIS PHARMACEUTICALS CORP |
未进口原研药品 |
||
22-212 |
醋酸奥曲肽注射液 |
Octreotide Acetate Injection/SANDOSTATIN |
5ml:1mg |
注射剂 |
NOVARTIS PHARMACEUTICALS CORP |
未进口原研药品 |
||
22-213 |
醋酸奥曲肽注射液 |
Octreotide Acetate Injection/SANDOSTATIN |
1ml:0.5mg |
注射剂 |
NOVARTIS PHARMACEUTICALS CORP |
未进口原研药品 |
||
22-214 |
醋酸奥曲肽注射液 |
Octreotide Acetate Injection/SANDOSTATIN |
5ml:5mg |
注射剂 |
NOVARTIS PHARMACEUTICALS CORP |
未进口原研药品 |
||
22-215 |
盐酸羟吗啡酮片 |
Oxymorphone hydrochloride tablets/OPANA |
5mg |
片剂 |
ENDO PHARMACEUTICALS INC |
未进口原研药品 |
||
22-216 |
盐酸羟吗啡酮片 |
Oxymorphone hydrochloride tablets/OPANA |
10mg |
片剂 |
ENDO PHARMACEUTICALS INC |
未进口原研药品 |
||
22-217 |
盐酸羟吗啡酮缓释片 |
oxymorphone hydrochloride extended-release tablets |
40mg |
片剂 |
IMPAX LABORATORIES INC |
美国上市的国际公认的同种药品 |
||
22-218 |
盐酸氢吗啡酮缓释片 |
Hydromorphone hydrochloride Prolonged-release tablets /JURNISTA |
4mg |
片剂 |
Janssen-Cilag SPA/Janssen-Cilag GmbH/Janssen-Cilag A/S |
未进口原研药品 |
||
22-219 |
盐酸氢吗啡酮缓释片 |
Hydromorphone hydrochloride Prolonged-release tablets /JURNISTA |
8mg |
片剂 |
Janssen-Cilag SPA/Janssen-Cilag GmbH/Janssen-Cilag A/S |
未进口原研药品 |
||
22-220 |
盐酸氢吗啡酮缓释片 |
Hydromorphone hydrochloride extended-release tablets /JURNISTA |
16mg |
片剂 |
v |
未进口原研药品 |
||
22-221 |
盐酸氢吗啡酮缓释片 |
Hydromorphone hydrochloride Prolonged-release tablets /JURNISTA |
32mg |
片剂 |
Janssen-Cilag SPA/Janssen-Cilag GmbH/Janssen-Cilag A/S |
未进口原研药品 |
||
22-222 |
盐酸氢吗啡酮缓释片 |
Hydromorphone hydrochloride Prolonged-release tablets /JURNISTA |
64mg |
片剂 |
Janssen-Cilag SPA/Janssen-Cilag GmbH/Janssen-Cilag A/S |
未进口原研药品 |
||
22-223 |
注射用醋酸地加瑞克 |
Degarelix Acetate for Injection /FIRMAGON(费蒙格) |
80mg(按地加瑞克(C82H103N18O16Cl)计算) |
注射剂 |
Ferring Pharmaceuticals A/S |
国内上市的原研药品 |
||
22-224 |
注射用醋酸地加瑞克 |
Degarelix Acetate for Injection /FIRMAGON(费蒙格) |
120mg(按地加瑞克(C82H103N18O16Cl)计算) |
注射剂 |
Ferring Pharmaceuticals A/S |
国内上市的原研药品 |
||
22-225 |
肠内营养乳剂(TPF-D) |
Enteral Nutritional Emulsion(TPF-D)/ Fresubin Diabetes(瑞代) |
500ml/袋 |
口服乳剂 |
Fresenius Kabi Deutschland GmbH |
国内上市的原研药品 |
||
22-226 |
肠内营养乳剂(TPF-D) |
Enteral Nutritional Emulsion(TPF-D)/ Fresubin Diabetes(瑞代) |
500ml/瓶 |
口服乳剂 |
Fresenius Kabi Deutschland GmbH |
国内上市的原研药品 |
||
22-227 |
肠内营养乳剂(TPF-D) |
Enteral Nutritional Emulsion(TPF-D)/ Fresubin Diabetes(瑞代) |
1000ml/袋 |
口服乳剂 |
Fresenius Kabi Deutschland GmbH |
国内上市的原研药品 |
||
22-228 |
注射用盐酸美法仑 |
Melphalan Hydrochloride for Injection/EVOMELA(迈维宁) |
50mg |
注射剂 |
Spectrum Pharmaceuticals, Inc./ Acrotech Biopharma,LLC |
国内上市的原研药品 |
||
22-229 |
注射用左亚叶酸钙 |
Levofolinate Calcium for Injection/ISOVORIN |
25mg |
注射剂 |
Pfizer Japan |
未进口原研药品 |
||
22-230 |
注射用左亚叶酸钙 |
Levoleucovorin Calcium for Injection/Fusilev |
50mg |
注射剂 |
ACROTECH BIOPHARMA LLC |
未进口原研药品 |
||
22-231 |
注射用左亚叶酸钙 |
Levofolinate Calcium for Injection/ISOVORIN |
100mg |
注射剂 |
Pfizer Japan |
未进口原研药品 |
||
22-232 |
注射用左亚叶酸钙 |
Levoleucovorin Calcium for Injection/Fusilev |
175mg |
注射剂 |
ACTAVIS LLC |
未进口原研药品 |
||
22-233 |
左亚叶酸钙注射液 |
Calcium Levofolinate Injection/ISOVORIN |
2.5ml:25mg |
注射剂 |
Pfizer Limited |
未进口原研药品 |
||
22-234 |
左亚叶酸钙注射液 |
Calcium Levofolinate Injection/ISOVORIN |
5ml:50mg |
注射剂 |
Pfizer Limited |
未进口原研药品 |
||
22-235 |
左亚叶酸钙注射液 |
Calcium Levofolinate Injection/ISOVORIN |
17.5ml:175mg |
注射剂 |
Pfizer Limited |
未进口原研药品 |
||
22-236 |
注射用左亚叶酸 |
Levoleucovorin for Injection/Khapzory |
175mg |
注射剂 |
Spectrum Pharmaceuticas,Inc/ACROTECH BIOPHARMA LLC |
未进口原研药品 |
||
22-237 |
注射用左亚叶酸 |
Levoleucovorin for Injection/Khapzory |
300mg |
注射剂 |
Spectrum Pharmaceuticas,Inc/ACROTECH BIOPHARMA LLC |
未进口原研药品 |
||
22-238 |
左亚叶酸注射液 |
Levofolinic acid Injection /Levofolic |
1ml:50ml |
注射剂 |
Medac GmbH |
未进口原研药品 |
||
22-239 |
左亚叶酸注射液 |
Levofolinic acid Injection/Levofolic |
4ml:200ml |
注射剂 |
Medac GmbH |
未进口原研药品 |
||
22-240 |
左亚叶酸注射液 |
Levofolinic acid Injection/Levofolic |
9ml:450ml |
注射剂 |
Medac GmbH |
未进口原研药品 |
||
22-241 |
米诺膦酸片 |
Minodronic acid Tablets/Recalbon |
1mg |
片剂 |
小野药品工业株式会社 |
未进口原研药品 |
||
22-242 |
米诺膦酸片 |
Minodronic acid Tablets/Bonoteo |
1mg |
片剂 |
アステラス製薬株式会社 |
未进口原研药品 |
||
22-243 |
米诺膦酸片 |
Minodronic acid Tablets/Recalbon |
50mg |
片剂 |
小野药品工业株式会社 |
未进口原研药品 |
||
22-244 |
米诺膦酸片 |
Minodronic acid Tablets/Bonoteo |
50mg |
片剂 |
アステラス製薬株式会社 |
未进口原研药品 |
||
22-245 |
米拉贝隆缓释片 |
Mirabegron Sustained-release Tablets/BETMIGA(贝坦利) |
25mg |
片剂 |
Astellas Pharma Europe B.V. |
国内上市的原研药品 |
||
22-246 |
米拉贝隆缓释片 |
Mirabegron Sustained-release Tablets/BETMIGA(贝坦利) |
50mg |
片剂 |
Astellas Pharma Europe B.V. |
国内上市的原研药品 |
||
22-247 |
帕利哌酮缓释片 |
Paliperidone Extended-Release Tablets/INVEGA(芮达) |
3mg |
片剂 |
Janssen-Cilag International NV |
国内上市的原研药品 |
||
22-248 |
帕利哌酮缓释片 |
Paliperidone Extended-Release Tablets/INVEGA(芮达) |
6mg |
片剂 |
Janssen-Cilag International NV |
国内上市的原研药品 |
||
22-249 |
帕利哌酮缓释片 |
Paliperidone Extended-Release Tablets/INVEGA(芮达) |
9mg |
片剂 |
Janssen-Cilag International NV |
国内上市的原研药品 |
||
22-250 |
卡泊三醇软膏 |
Calcipotriol Ointment/Daivonex(达力士) |
0.005%(15g:0.75mg) |
软膏剂 |
LEO Pharma A/S |
国内上市的原研药品 |
||
22-251 |
卡泊三醇软膏 |
Calcipotriol Ointment/Daivonex(达力士) |
0.005%(30g:1.50mg) |
软膏剂 |
LEO Pharma A/S |
国内上市的原研药品 |
||
22-252 |
麦考酚钠肠溶片 |
Mycophenolate Sodium Enteric-coated tablets/Myfortic(米芙) |
180mg |
片剂 |
Novartis Pharma GmbH/Novartis Pharma Schweiz AG |
国内上市的原研药品 |
||
22-253 |
麦考酚钠肠溶片 |
Mycophenolate Sodium Enteric-coated tablets/Myfortic |
360mg |
片剂 |
Novartis Pharmaceuticals Corporation |
未进口原研药品 |
||
22-254 |
注射用醋酸亮丙瑞林微球 |
Leuprorelin Acetate Microspheres for Injection/ Enantone(抑那通) |
1.88mg |
注射剂 |
Takeda Pharmaceutical Company Limited |
国内上市的原研药品 |
||
22-255 |
注射用醋酸亮丙瑞林微球 |
Leuprorelin Acetate Microspheres for Injection / Enantone(抑那通) |
3.75mg |
注射剂 |
Takeda Pharmaceutical Company Limited |
国内上市的原研药品 |
||
22-256 |
注射用醋酸亮丙瑞林微球 |
Leuprorelin Acetate Microspheres for Injection |
11.25mg |
注射剂 |
Takeda Pharmaceutical Company Limited |
国内上市的原研药品 |
||
22-257 |
注射用醋酸亮丙瑞林微球 |
Leuprorelin Acetate Microspheres for Injection/LUPRONDEPOT/LUPRONDEPOT-PED |
7.5mg |
注射剂 |
ABBVIE ENDOCRINE INC |
未进口原研药品 |
||
22-258 |
注射用醋酸亮丙瑞林微球 |
Leuprorelin Acetate Microspheres for Injection/LUPRONDEPOT-PED |
15mg |
注射剂 |
ABBVIE ENDOCRINE INC |
未进口原研药品 |
||
22-259 |
注射用醋酸亮丙瑞林微球 |
Leuprorelin Acetate Microspheres for Injection/LUPRONDEPOT |
22.5mg |
注射剂 |
ABBVIE ENDOCRINE INC |
未进口原研药品 |
||
22-260 |
注射用醋酸亮丙瑞林微球 |
Leuprorelin Acetate Microspheres for Injection/LUPRONDEPOT/LUPRONDEPOT-PED |
30mg |
注射剂 |
ABBVIE ENDOCRINE INC |
未进口原研药品 |
||
22-261 |
注射用醋酸亮丙瑞林微球 |
Leuprorelin Acetate Microspheres for Injection/LUPRONDEPOT |
45mg |
注射剂 |
ABBVIE ENDOCRINE INC |
未进口原研药品 |
||
22-262 |
注射用吗替麦考酚酯 |
Mycophenolate Mofetil for Injection /CELLCEPT |
500mg |
注射剂 |
ROCHE PALO ALTO LLC |
未进口原研药品 |
||
22-263 |
注射用吗替麦考酚酯 |
Mycophenolate Mofetil for Injection /CELLCEPT |
500mg |
注射剂 |
ROCHE PALO ALTO LLC |
未进口原研药品 |
||
22-264 |
复方氨基酸注射液(17AA-Ⅲ) |
Compound Amino Acids Injection(17AA-Ⅲ)/MORIHEPAMIN |
500mL:37.925g(总氨基酸) |
注射剂 |
广州绿十字制药有限公司/广州绿十字制药股份有限公司 |
经审核确定的国外原研企业在中国境内生产的药品 |
||
22-265 |
复方氨基酸注射液(18AA-Ⅸ) |
Compound Amino Acids Injection(18AA-Ⅸ)/NEOAMIYU |
200mL:12.250g(总氨基酸) |
注射剂 |
广州绿十字制药有限公司/广州绿十字制药股份有限公司 |
经审核确定的国外原研企业在中国境内生产的药品 |
||
22-266 |
舒更葡糖钠注射液 |
Sugammadex Sodium Injection/BRIDION(布瑞亭) |
按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算 2ml:200mg |
注射剂 |
Merck Sharp & Dohme Limited/Merck Sharp & Dohme B.V. |
国内上市的原研药品 |
||
22-267 |
舒更葡糖钠注射液 |
Sugammadex Sodium Injection/BRIDION(布瑞亭) |
按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算 5ml:500mg |
注射剂 |
Merck Sharp & Dohme Limited/Merck Sharp & Dohme B.V. |
国内上市的原研药品 |
||
22-268 |
碳酸镧咀嚼片 |
Lanthanum Carbonate Chewable Tablets/Fosrenol(福斯利诺) |
500mg |
片剂 |
Shire Pharmaceuticals Ireland Limited/Takeda Pharmaceuticals International AG Ireland Branch |
国内上市的原研药品 |
||
22-269 |
碳酸镧咀嚼片 |
Lanthanum Carbonate Chewable Tablets/Fosrenol/Foznol |
250mg |
片剂 |
Shire Pharmaceutical Contracts Ltd |
未进口原研药品 |
||
22-270 |
碳酸镧咀嚼片 |
Lanthanum Carbonate Chewable Tablets/Fosrenol(福斯利诺) |
750mg |
片剂 |
Shire Pharmaceuticals Ireland Limited/Takeda Pharmaceuticals International AG Ireland Branch |
国内上市的原研药品 |
||
22-271 |
碳酸镧咀嚼片 |
Lanthanum Carbonate Chewable Tablets/Fosrenol(福斯利诺) |
1000mg |
片剂 |
Shire Pharmaceuticals Ireland Limited/Takeda Pharmaceuticals International AG Ireland Branch |
国内上市的原研药品 |
||
22-272 |
替米沙坦氨氯地平片 |
Telmisartan and Amlodipine Tablets/Twynsta(双加) |
每片含替米沙坦 80mg 与苯磺酸氨氯地平 5mg(按照氨氯地平计算) |
片剂 |
Boehringer Ingelheim International GmbH |
国内上市的原研药品 |
||
22-273 |
替米沙坦氨氯地平片 |
Telmisartan and Amlodipine Tablets/Twynsta |
40mg/5mg |
片剂 |
Boehringer Ingelheim International GmbH |
未进口原研药品 |
||
22-274 |
替米沙坦氨氯地平片 |
Telmisartan and Amlodipine Tablets/TWYNSTA |
EQ 5MG BASE;40MG |
片剂 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
未进口原研药品 |
||
22-275 |
替米沙坦氨氯地平片 |
Telmisartan and Amlodipine Tablets/Twynsta |
40mg/10mg |
片剂 |
Boehringer Ingelheim International GmbH |
未进口原研药品 |
||
22-276 |
替米沙坦氨氯地平片 |
Telmisartan and Amlodipine Tablets/TWYNSTA |
EQ 10MG BASE;40MG |
片剂 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
未进口原研药品 |
||
22-277 |
替米沙坦氨氯地平片 |
Telmisartan and Amlodipine Tablets/Twynsta |
80mg/10mg |
片剂 |
Boehringer Ingelheim International GmbH |
未进口原研药品 |
||
22-278 |
替米沙坦氨氯地平片 |
Telmisartan and Amlodipine Tablets/TWYNSTA |
EQ 10MG BASE;80MG |
片剂 |
BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
未进口原研药品 |
||
22-279 |
他卡西醇软膏 |
Tacalcitol Ointment/Bonalfa(萌尔夫) |
2μg/g(10g×1支/盒) |
软膏剂 |
TEIJIN PHARMA LIMITED |
国内上市的原研药品 |
||
22-280 |
他卡西醇软膏 |
Tacalcitol Ointment/Bonalfa(萌尔夫) |
2μg/g(30g×1支/盒) |
软膏剂 |
TEIJIN PHARMA LIMITED |
国内上市的原研药品 |
||
22-281 |
他卡西醇软膏 |
Tacalcitol Ointment/Bonalfa |
20μg/g(10g×1支/盒) |
软膏剂 |
帝人ファーマ株式会社 |
未进口原研药品 |
||
22-282 |
吸入用色甘酸钠溶液 |
Sodium cromoglicate solution for inhalation/ LOMUDAL |
2ml: 20mg |
吸入用溶液剂 |
SANOFI |
未进口原研药品 |
||
22-283 |
吸入用色甘酸钠溶液 |
Sodium cromoglicate solution for inhalation/Intal |
2ml: 20mg |
吸入用溶液剂 |
サノフィ株式会社 |
未进口原研药品 |
||
22-284 |
盐酸安非他酮缓释片 |
Bupropion hydrochloride sustained-release tablets/WELLBUTRIN SR |
100mg |
片剂(缓释片) |
GlaxoSmithKline |
未进口原研药品 |
||
22-285 |
盐酸安非他酮缓释片 |
Bupropion hydrochloride sustained-release tablets /WELLBUTRIN SR/ZYBAN |
150mg |
片剂(缓释片) |
GlaxoSmithKline |
未进口原研药品 |
||
22-286 |
盐酸安非他酮缓释片 |
Bupropion hydrochloride extended-release tablets/WELLBUTRIN XL |
150mg |
片剂(缓释片) |
Valeant International Barbados SRL/Bausch Health US LLC |
未进口原研药品 |
||
22-287 |
盐酸安非他酮缓释片 |
Bupropion hydrochloride sustained-release tablets/WELLBUTRIN SR |
200mg |
片剂(缓释片) |
GlaxoSmithKline |
未进口原研药品 |
||
22-288 |
盐酸安非他酮缓释片 |
Bupropion hydrochloride extended-release tablets/WELLBUTRIN XL |
300mg |
片剂(缓释片) |
Valeant International Barbados SRL/Bausch Health US LLC |
未进口原研药品 |
||
22-289 |
盐酸安非他酮缓释片 |
Bupropion hydrochloride extended-release tablets/FORFIVO XL |
450mg |
片剂(缓释片) |
Alvogen Group Holdings LLC |
未进口原研药品 |
||
22-290 |
曲前列尼尔注射液 |
Treprostinil Injection/REMODULIN |
20mg/20ml(1mg/ml) |
注射剂 |
United Therapeutics Corporation |
未进口原研药品 |
||
22-291 |
曲前列尼尔注射液 |
Treprostinil Injection/REMODULIN |
1mg/ml,装量20ml |
注射剂 |
United Therapeutics Europe Ltd /Ferrer Internacional, S.A. |
未进口原研药品 |
||
22-292 |
曲前列尼尔注射液 |
Treprostinil Injection/TREPROST |
20mg,装量20ml |
注射剂 |
持田製薬株式会社 |
未进口原研药品 |
||
22-293 |
曲前列尼尔注射液 |
Treprostinil Injection/REMODULIN |
50mg/20ml(2.5mg/ml) |
注射剂 |
United Therapeutics Corporation |
未进口原研药品 |
||
22-294 |
曲前列尼尔注射液 |
Treprostinil Injection/REMODULIN |
2.5mg/ml,装量20ml |
注射剂 |
United Therapeutics Europe Ltd /Ferrer Internacional, S.A. |
未进口原研药品 |
||
22-295 |
曲前列尼尔注射液 |
Treprostinil Injection/TREPROST |
50mg,装量20ml |
注射剂 |
持田製薬株式会社 |
未进口原研药品 |
||
22-296 |
曲前列尼尔注射液 |
Treprostinil Injection/REMODULIN |
100mg/20ml(5mg/ml) |
注射剂 |
United Therapeutics Corporation |
未进口原研药品 |
||
22-297 |
曲前列尼尔注射液 |
Treprostinil Injection/REMODULIN |
5mg/ml,装量20ml |
注射剂 |
United Therapeutics Europe Ltd /Ferrer Internacional, S.A. |
未进口原研药品 |
||
22-298 |
曲前列尼尔注射液 |
Treprostinil Injection/TREPROST |
100mg,装量20ml |
注射剂 |
持田製薬株式会社 |
未进口原研药品 |
||
22-299 |
曲前列尼尔注射液 |
Treprostinil Injection/REMODULIN |
200mg/20ml(10mg/ml) |
注射剂 |
United Therapeutics Corporation |
未进口原研药品 |
||
22-300 |
曲前列尼尔注射液 |
Treprostinil Injection/REMODULIN |
10mg/ml,装量20ml |
注射剂 |
United Therapeutics Europe Ltd /Ferrer Internacional, S.A. |
未进口原研药品 |
1.网站数据库说明:本网站所有仿制药参比制剂目录数据源自国家药品监督管理局官方网站;
2.参比制剂选择原则:有原研进口的应选择原研进口药作为参比制剂首选;


